Trends in surgery for crohn's disease in the era of infliximab

Annals of Surgery

Volumn 252, Issue 2, 2010, Pages 307-312

  Jones, Douglas W ^a   Finlayson, Samuel R G ^b,c  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB;

ABSCESS DRAINAGE; ANUS FISTULA; ARTICLE; COLON RESECTION; COLORECTAL SURGERY; CROHN DISEASE; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; IMMUNOMODULATION; INTESTINE FISTULA; PERIANAL ABSCESS; PRIORITY JOURNAL; RECTUM RESECTION;

ADULT; AGED; ANTIBODIES, MONOCLONAL; CROHN DISEASE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; UNITED STATES;

EID: 77955170773     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181e61df5     Document Type: Article

References (23)

1. Plevy SE, Landers CJ, Prehn J, et al. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol. 1997;159:6276-6282.
2. Targan SR, Hannauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor a for Crohn's disease. N Engl J Med. 1997;337:1029-1035.
3. Hanauer SB, Feagan BG, Lichtensetin GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomized trial. Lancet. 2002;359:1541-1549.
4. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas inpatients with Crohn's disease. N Engl J Med. 1999;340:1398-1405. (Pubitemid 29205403)
5. Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med. 2004;350:876-885.
6. Lichtenstein GR, Abreu MT, Cohen R, et al. American gastroenterological association institute medical position statement on corticosteroids, immuno-modulators, and infliximab in inflammatory bowel disease. Gastroenterology. 2006;130:935-939. (Pubitemid 43374542)
7. Rubenstein JH, Chong RY, Cohen RD. Infliximab decreases resource use among patients with Crohn's disease. J Clin Gastroenterol. 2002;35:151-156.
8. Lichtenstein GR, Yan S, Bala M, et al. Infliximab maintenance treatment reduces hospitalizations, surgeries and procedures in fistulizing Crohn's disease. Gastroenterology. 2005;128:862-869.
9. Poritz LS, Rowe WA, Koltun WA. Remicade does not abolish the need for surgery in fistulizing Crohn's disease. Dis Colon Rectum. 2002;45:771-775.
10. Bewtra M, Su C, Lewis JD. Trends in hospitalization rates for inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol. 2007;5:597-601.
11. Nguyen GC, Tuskey A, Dassopoulos T, et al. Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. Inflamm Bowel Dis. 2007;13:1529-1535.
12. Osterman MT, Lichtenstein GR. Infliximab in fistulizing Crohn's disease. Gastroenterol Clin North Am. 2006;35:795-820.
13. Quan H, Parsons RN, Ghali WA. Validity of procedure codes in international classification of diseases, 9th revision, clinical modification administrative data. Med Care. 2004;42:801-809.
14. Hurst RD, Molinari M, Rubin M, et al. Prospective study of the features, indications and surgical treatment in 513 consecutive patients affected by Crohn's disease. Surgery. 1997;122:661-667.
15. Schwartz DA, Loftus EV Jr, Tremaine WJ, et al. The natural history of fistulizing Crohn's disease in Olmsted county, Minnesota. Gastroenterology. 2002;122:875-880.
16. Michelassi F, Stella M, Balestracci T, et al. Incidence, diagnosis, and treatment of enteric and colorectal fistulae in patients with Crohn's disease. Ann Surg. 1993;218:660-666.
17. van Bodegraven AA, Sloots CE, Felt-Bersma RJ, et al. Endosonographic evidence of persistence of Crohn's disease-associated fistulas after infliximab treatment, irrespective of clinical response. Dis Colon Rectum. 2002;45:39-46.
18. van Assche G, Vanbeckevoort D, Bielen D, et al. Magnetic resonance imaging of the effect of infliximab on perianal fistulizing Crohn's disease. Am J Gastroenterol. 2003;98:332-339.
19. Bernstein CN, Nabalamba A. Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study. Am J Gastroenterol. 2006;101: 110-118.
20. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424-1429.
21. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004; 126:1504-1517.
22. Loftus CG, Loftus EV Jr, Harmsen WS, et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis. 2007;13:254-261.
23. Loftus EV Jr. The burden of inflammatory bowel disease in the United States: a moving target? Clin Gastroenterol Hepatol. 2007;5:1383-1384.